Hirase, Takashi
Ling, Jeremiah F.
Haghshenas, Varan
Fuld, Richard III
Dong, David
Hanson, Darrell S.
Meyer, B. Christoph
Marco, Rex A. W.
Article History
Received: 7 August 2021
Accepted: 1 June 2022
First Online: 4 June 2022
Declarations
:
: Ethics approval was obtained from the Houston Methodist Hospital Institutional Review Board on April 13, 2020 (Approval No. PRO00024733). The study was in accordance with guidelines and regulations. The need for Informed Consent was waived by the Houston Methodist Hospital Institutional Review Board Ethics Committee due to the retrospective nature of the study.
: Not applicable.
: Takashi Hirase, Jeremiah Ling, Varan Haghshenas, Richard Fuld III, David Dong, and B Christoph Meyer declare no potential conflicts of interest with respect to research, authorship, and/or publication of this article.Rex AW Marco has the following disclosures:DePuy, A Johnson & Johnson Company: Paid presenter or speaker; Globus Medical: Paid presenter or speaker; Musculoskeletal Tumor Society: Board or committee member; Stryker: Paid presenter or speaker; Synaptive Medical: Paid presenter or speaker.Darrell S Hanson has the following disclosures:DePuy, A Johnson & Johnson Company: IP royalties; Paid consultant; Paid presenter or speaker; Medtronic Sofamor Danek: Paid consultant; Paid presenter or speaker.